Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN116496215A details efficient palladium-catalyzed cascade reaction for quinolinone compounds offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108148070B details a novel Rh-catalyzed one-pot synthesis of furanone isoquinolinones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed carbonylation patent CN117164506B enables efficient pharmaceutical intermediates manufacturing with reduced costs.
Novel iodine-promoted method using DMF as carbon source. High efficiency, scalable process for pharmaceutical intermediates and bioactive inhibitors.
Novel one-step Pd-catalyzed carbonylation for benzofuran-3-carboxamides. Reduces steps, uses cheap nitroarenes. Ideal for pharma intermediate supply chains.
Patent CN115260080B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity indole-3-carboxamide with substantial cost and supply chain advantages for global pharmaceutical manufacturing.
Patent CN113045489B details a novel Pd-catalyzed route for quinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115353482B reveals metal-free synthesis for selenium substituted compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel quinoline imidazole ligand enables high-yield asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN110156800A reveals mild NHC-catalyzed synthesis for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain solutions.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones. Offers cost reduction and scalable manufacturing for pharma intermediates.
Analysis of patent CN104774202B reveals a one-pot copper-catalyzed route for 9H-pyrido[2,3-b]indole derivatives offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115785110A discloses a novel Pd-catalyzed synthesis of indolinotetrahydropyran compounds. Offers high yield, mild conditions, and antitumor potential for pharmaceutical manufacturing.
Patent CN116640146A details efficient Pd-catalyzed route. Delivers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl quinazolinones. Offers cost reduction and scalable routes for pharmaceutical intermediates.
Patent CN115403505B reveals efficient palladium-catalyzed route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds. High enantioselectivity, mild conditions, scalable for API manufacturing.
Novel isoindolone-based antitumor compound synthesis patent CN119874717B. Mild conditions, high yield. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN112480015B details a Pd-catalyzed carbonylation method for quinazolinones. This breakthrough offers cost-effective, scalable routes for high-purity API intermediates.
Discover the novel photocatalytic synthesis of heterocyclic cyclopropanes from patent CN112898202B. A mild, high-yield route for pharmaceutical intermediates manufacturing.